SCHEMBL7937735

SCHEMBL7937735

COc1ccc2c(c1)NCC2C(=O)C(=O)N(CC(=O)NCCN1CCCC1=O)CC1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 5/20 0.41
NPC1 O15118 1/20 0.39
ATM Q13315 1/20 0.39
NQO2 P16083 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
POLB P06746 1/20 0.35
RCE1 Q9Y256 1/20 0.35
CYP1A2 P05177 1/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
BRD4 O60885 1/20 0.35
CREBBP Q92793 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969063 0.89 CYP2D6 (0.42) KMT2AALDH1A1POLBGAA
SCHEMBL7938408 0.86 CYP2C9 (0.43) KMT2AALDH1A1TDP1POLBGAA
SCHEMBL7951892 0.85 POLB (0.39) ALDH1A1NPC1POLBHTT
SCHEMBL7944071 0.83 HTT (0.40) ALDH1A1NPC1MTNR1AMTNR1BPOLB
SCHEMBL7948016 0.83 POLB (0.38) KMT2AALDH1A1NPC1ATMSMN1; SMN2
SCHEMBL7945520 0.82 NPC1 (0.39) KMT2AALDH1A1NPC1SMN1; SMN2MTNR1A
SCHEMBL7982206 0.82 POLB (0.36) KMT2AALDH1A1NPC1NQO2MTNR1A
SCHEMBL7947094 0.81 POLB (0.37) KMT2AALDH1A1NPC1ATMSMN1; SMN2
SCHEMBL7946743 0.81 MITF (0.45) KMT2AALDH1A1NPC1ATMSMN1; SMN2
SCHEMBL7951886 0.81 MITF (0.45) KMT2AALDH1A1NPC1ATMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010035032-A1 CALCIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2010-04-01 WO disclosed
WO-2009133387-A1 INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS LECTUS THERAPEUTICS LIMITED (GB) 2009-11-05 WO disclosed